Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis
Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis have?
Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis has 35 citations in the OpenAlex counts ScholarIQ stores.
When was Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis published?
Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis has 2020 year in the ScholarIQ index.
What is the open-access status of Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis?
Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis has bronze oa status in the ScholarIQ index.
What is the DOI of Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis?
The DOI for Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis is on the source record.
What is the PMID of Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis?
The PMID for Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis is on the source record.
What is the OpenAlex record for Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis?
The OpenAlex for Targeting transthyretin ‐ Mechanism‐based treatment approaches and future perspectives in hereditary amyloidosis is on the source record.